Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +38.35%
#3 Glidr Glidr +36.87%
#4 Humanity Humanity +28.61%
#5 Collector Crypt Collector Crypt +19.82%
#6 Walrus Walrus +18.37%
#7 Codatta Codatta +18.00%
#8 Provenance Blockchain Provenance Blockchain +16.83%
#9 Enso Enso +15.35%
#10 The Black Bull The Black Bull +14.70%
Coin of the day
EXOD EXOD
설정
언어
한국어
통화
USD
테마
Trimurthi Limited Trimurthi Limited

Trimurthi Limited

TRIMURTHI
주식 순위 #36550
Trimurthi Limited functions as a parent company primarily engaged in the... Trimurthi Limited functions as a parent company primarily engaged in the pharmaceutical sector, encompassing the distribution, retail, and promotion of various medical products. Its business operations are structured across several divisions, including its core pharmaceutical ventures, financial services, investment activities, and equity trading. The company's product portfolio features medicines for family planning, women's health (obstetrics and gynecology), gastrointestinal conditions, and other therapeutic areas. Established on December 13, 1994, its corporate headquarters are situated in Hyderabad, India.
주가
$0.31247377
마지막 동기화: 2025-04-21
시가총액
$2.56M
변동 (1일)
0.67%
변동 (1년)
0.00%
국가
IN
거래 Trimurthi Limited (TRIMURTHI)

카테고리

Healthcare
Trimurthi Limited (TRIMURTHI)의 주식 분할 이력
Trimurthi Limited 주식 (심볼: TRIMURTHI)은 총 2회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Oct 04, 2010에 발생했습니다.
Oct 15, 2009 이전에 매수한 TRIMURTHI 주식 1주는 현재 1주의 TRIMURTHI 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
2010-10-04 1:10 x0.1 x1
2009-10-15 10:1 x10 x10
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 0 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 0 -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 0 -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 0 -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 0 -
US